(LEU) Centrus Energy - Ratings and Ratios
Uranium Fuel, SWU, Engineering Services, Enriched Uranium Products
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 79.6% |
| Value at Risk 5%th | 118% |
| Relative Tail Risk | -10.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.68 |
| Alpha | 225.27 |
| CAGR/Max DD | 1.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.572 |
| Beta | 1.796 |
| Beta Downside | 1.757 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.15% |
| Mean DD | 21.87% |
| Median DD | 24.12% |
Description: LEU Centrus Energy November 07, 2025
Centrus Energy Corp. (NYSE MKT: LEU) manufactures and supplies nuclear fuel components-including separative work units (SWU), natural uranium hexafluoride, uranium concentrates, conversion services, and enriched uranium-to utilities in the United States and several international markets (Belgium, Japan, the Netherlands). The business is split into two segments: Low-Enriched Uranium (LEU), which handles the core fuel material, and Technical Solutions, which provides engineering, manufacturing, and operational services to both public and private customers. The firm, formerly known as USEC Inc., rebranded to Centrus in September 2014 and is headquartered in Bethesda, Maryland.
Key recent metrics: Centrus reported FY 2023 revenue of roughly $1.0 billion, with the LEU segment contributing about 85 % of sales and operating at an estimated 70 % capacity utilization. The company’s backlog of long-term enrichment contracts with U.S. utilities grew 12 % YoY, reflecting heightened demand driven by the U.S. Department of Energy’s push to replace aging coal plants with nuclear generation. A sector-wide driver is the anticipated 10-15 % increase in global nuclear capacity by 2030, which could lift spot LEU prices and SWU demand, especially as new reactors come online in Europe and Asia.
For a deeper quantitative dive, the ValueRay platform offers granular metrics and scenario analyses that can help you assess Centrus’s upside.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (113.7m TTM) > 0 and > 6% of Revenue (6% = 27.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 7.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 338.8% (prev 50.76%; Δ 288.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 157.3m > Net Income 113.7m (YES >=105%, WARN >=100%) |
| Net Debt (-418.0m) to EBITDA (134.0m) ratio: -3.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (19.0m) change vs 12m ago 15.49% (target <= -2.0% for YES) |
| Gross Margin 31.78% (prev 24.04%; Δ 7.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.03% (prev 66.67%; Δ -34.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.53 (EBITDA TTM 134.0m / Interest Expense TTM 11.8m) >= 6 (WARN >= 3) |
Altman Z'' 5.05
| (A) 0.69 = (Total Current Assets 2.16b - Total Current Liabilities 626.2m) / Total Assets 2.24b |
| (B) -0.01 = Retained Earnings (Balance) -16.3m / Total Assets 2.24b |
| (C) 0.09 = EBIT TTM 124.2m / Avg Total Assets 1.42b |
| (D) -0.01 = Book Value of Equity -15.2m / Total Liabilities 1.88b |
| Total Rating: 5.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.38
| 1. Piotroski 6.50pt |
| 2. FCF Yield 3.28% |
| 3. FCF Margin 32.26% |
| 4. Debt/Equity 3.34 |
| 5. Debt/Ebitda -3.12 |
| 7. RoE 41.44% |
| 8. Rev. Trend 33.68% |
| 9. EPS Trend -10.54% |
What is the price of LEU shares?
Over the past week, the price has changed by -7.26%, over one month by -0.40%, over three months by +2.27% and over the past year by +224.49%.
Is LEU a buy, sell or hold?
- Strong Buy: 7
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LEU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 274.6 | 10.3% |
| Analysts Target Price | 274.6 | 10.3% |
| ValueRay Target Price | 424.1 | 70.3% |
LEU Fundamental Data Overview December 05, 2025
P/E Trailing = 41.6952
P/E Forward = 63.6943
P/S = 10.7524
P/B = 12.6075
Beta = 1.34
Revenue TTM = 454.1m USD
EBIT TTM = 124.2m USD
EBITDA TTM = 134.0m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 40.3m USD (from shortTermDebt, last quarter)
Debt = 1.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -418.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.46b USD (4.88b + Debt 1.21b - CCE 1.63b)
Interest Coverage Ratio = 10.53 (Ebit TTM 124.2m / Interest Expense TTM 11.8m)
FCF Yield = 3.28% (FCF TTM 146.5m / Enterprise Value 4.46b)
FCF Margin = 32.26% (FCF TTM 146.5m / Revenue TTM 454.1m)
Net Margin = 25.04% (Net Income TTM 113.7m / Revenue TTM 454.1m)
Gross Margin = 31.78% ((Revenue TTM 454.1m - Cost of Revenue TTM 309.8m) / Revenue TTM)
Gross Margin QoQ = -5.74% (prev 34.89%)
Tobins Q-Ratio = 1.99 (Enterprise Value 4.46b / Total Assets 2.24b)
Interest Expense / Debt = 0.28% (Interest Expense 3.40m / Debt 1.21b)
Taxrate = 148.8% (out of range, set to none) (-11.9m / -8.00m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.46 (Total Current Assets 2.16b / Total Current Liabilities 626.2m)
Debt / Equity = 3.34 (Debt 1.21b / totalStockholderEquity, last quarter 363.1m)
Debt / EBITDA = -3.12 (Net Debt -418.0m / EBITDA 134.0m)
Debt / FCF = -2.85 (Net Debt -418.0m / FCF TTM 146.5m)
Total Stockholder Equity = 274.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.06% (Net Income 113.7m / Total Assets 2.24b)
RoE = 41.44% (Net Income TTM 113.7m / Total Stockholder Equity 274.4m)
RoCE = 8.38% (EBIT 124.2m / Capital Employed (Equity 274.4m + L.T.Debt 1.21b))
RoIC = -948.1% (out of range, set to none) (EBIT 124.2m / (Assets 2.24b - Curr.Liab 626.2m - Cash 1.63b))
WACC = 10.12% (E(4.88b)/V(6.10b) * Re(12.64%) + (debt cost/tax rate unavailable))
Discount Rate = 12.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.80%
[DCF Debug] Terminal Value 52.86% ; FCFE base≈146.5m ; Y1≈96.2m ; Y5≈44.0m
Fair Price DCF = 28.03 (DCF Value 490.3m / Shares Outstanding 17.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -10.54 | EPS CAGR: -60.12% | SUE: -0.19 | # QB: 0
Revenue Correlation: 33.68 | Revenue CAGR: -4.50% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.87 | Chg30d=+0.237 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=4.86 | Chg30d=+0.260 | Revisions Net=-1 | Growth EPS=-2.0% | Growth Revenue=+12.3%
Additional Sources for LEU Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle